Psilocybin in Chronic Low Back Pain and Depression

PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 22, 2024

Primary Completion Date

July 30, 2026

Study Completion Date

August 30, 2026

Conditions
Chronic Low-back PainDepression
Interventions
DRUG

Psilocybin

Drug administration under supportive conditions

DRUG

Methylphenidate

Drug administration under supportive conditions

Trial Locations (1)

21224

RECRUITING

Johns Hopkins University School of Medicine, Baltimore

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

Johns Hopkins University

OTHER